StevenFerencKomjathyMD
Internal Medicine • Thousand Oaks, CAAddiction Medicine, Allergy & Immunology, Clinical Pharmacology
CMO St Andrews Global Medical Consulting
Dr. Komjathy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
268 Erbes Rd.
Thousand Oaks, CA 91362Phone+1 412-421-0279- Is this information wrong?
Summary
- Expert in Global drug development
Education & Training
Novant Health New Hanover Regional Medical CenterResidency, Internal Medicine, 1996 - 1999
University of Maryland School of MedicineClass of 1996
Certifications & Licensure
NC State Medical License 2006 - 2025
Clinical Trials
- A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects Start of enrollment: 2006 Apr 01
- Phase I Study of PSD502 (Lidocaine Prilocaine Spray) Applied to the Glans Penis up to Three Times a Day for 21 Days in Healthy Male Volunteers Start of enrollment: 2007 Mar 01
- A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder) Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- 34 citationsOrally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease.Robert A. Hauser, Stuart Isaacson, Aaron Ellenbogen, Beth Safirstein, Daniel D. Truong, Steven F. Komjathy, Deena M. Kegler-Ebo, Ping Zhao, Charles Oh> ;Parkinsonism & Related Disorders. 2019 Jul 1
- 56 citationsBest practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studies.Lichuan Liu, Akintunde Bello, Mark J. Dresser, Donald Heald, Steven F. Komjathy, Edward O'Mara, Mark Rogge, S. Aubrey Stoch, Sarah Robertson> ;Journal of Clinical Pharmacology. 2016 Feb 1
- 121 citationsThe Potent BACE1 Inhibitor LY2886721 Elicits Robust Central Aβ Pharmacodynamic Responses in Mice, Dogs, and Humans, , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;The Journal of Neuroscience. 2015 Jan 21
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
